These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 14649771)

  • 1. Relative versus absolute noncontagiousness of respiratory tuberculosis on treatment.
    Long R; Bochar K; Chomyc S; Talbot J; Barrie J; Kunimoto D; Tilley P
    Infect Control Hosp Epidemiol; 2003 Nov; 24(11):831-8. PubMed ID: 14649771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis.
    Su WJ; Feng JY; Chiu YC; Huang SF; Lee YC
    Eur Respir J; 2011 Feb; 37(2):376-83. PubMed ID: 20516049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC;
    Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non conversion of sputum smears in new smear positive pulmonary tuberculosis patients in Yaoundé, Cameroon.
    Kuaban C; Bame R; Mouangue L; Djella S; Yomgni C
    East Afr Med J; 2009 May; 86(5):219-25. PubMed ID: 20084990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New recommendations for duration of respiratory isolation based on time to detect Mycobacterium tuberculosis in liquid culture.
    Ritchie SR; Harrison AC; Vaughan RH; Calder L; Morris AJ
    Eur Respir J; 2007 Sep; 30(3):501-7. PubMed ID: 17537768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis?
    Wilkinson D; Bechan S; Connolly C; Standing E; Short GM
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):52-5. PubMed ID: 9562111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.
    Shibabaw A; Gelaw B; Wang SH; Tessema B
    PLoS One; 2018; 13(6):e0198080. PubMed ID: 29944658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure.
    Ambreen A; Jamil M; Rahman MAU; Mustafa T
    BMC Infect Dis; 2019 Oct; 19(1):923. PubMed ID: 31666021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis.
    Botha FJ; Sirgel FA; Parkin DP; van de Wal BW; Donald PR; Mitchison DA
    S Afr Med J; 1996 Feb; 86(2):155-8. PubMed ID: 8619142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to sputum conversion in smear positive pulmonary TB patients on category I DOTS and factors delaying it.
    Parikh R; Nataraj G; Kanade S; Khatri V; Mehta P
    J Assoc Physicians India; 2012 Aug; 60():22-6. PubMed ID: 23405517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative sputum bacillary load during rifampin-containing short course chemotherapy in human immunodeficiency virus-infected and non-infected adults with pulmonary tuberculosis.
    Joloba ML; Johnson JL; Namale A; Morrissey A; Assegghai AE; Mugerwa RD; Ellner JJ; Eisenach KD
    Int J Tuberc Lung Dis; 2000 Jun; 4(6):528-36. PubMed ID: 10864183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum levels of iron, copper, and zinc, and inflammatory markers with bacteriological sputum conversion during tuberculosis treatment.
    Moraes ML; Ramalho DM; Delogo KN; Miranda PF; Mesquita ED; de Melo Guedes de Oliveira HM; Netto AR; Dos Anjos MJ; Kritski AL; de Oliveira MM
    Biol Trace Elem Res; 2014 Aug; 160(2):176-84. PubMed ID: 24958018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged positivity of sputum smears with negative cultures during treatment for pulmonary tuberculosis.
    van der Kuyp F; Mahan CS
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1663-7. PubMed ID: 23131266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yield of continued monthly sputum evaluation among tuberculosis patients after culture conversion.
    Sundaram V; Fujiwara PI; Driver CR; Osahan SS; Munsiff SS
    Int J Tuberc Lung Dis; 2002 Mar; 6(3):238-45. PubMed ID: 11934142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sputum smear conversion during intensive TB treatment phase according to HIV status, in hospitalised patients in Togo].
    Wateba MI; Diop SA; Salou M; Womitso K; Nichols S; Tidjani O
    Med Mal Infect; 2011 Mar; 41(3):140-4. PubMed ID: 21282024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):707-12. PubMed ID: 1901200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sputum conversion among patients with pulmonary tuberculosis: are there implications for removal of respiratory isolation?
    Fortún J; Martín-Dávila P; Molina A; Navas E; Hermida JM; Cobo J; Gómez-Mampaso E; Moreno S
    J Antimicrob Chemother; 2007 Apr; 59(4):794-8. PubMed ID: 17392354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.